Phase 2 Cerebral Amyloid Angiopathy Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Cerebral Amyloid Angiopathy
Alnylam Pharmaceuticals200 enrolled57 locationsNCT06393712
Recruiting
Phase 2
A Study of AMDX-2011P in Participants With CAA
Cerebral Amyloid Angiopathy
Amydis Inc.25 enrolled1 locationNCT05709314
Recruiting
Phase 2
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Cerebral Amyloid AngiopathyIntracerebral Hemorrhage Lobar
Huashan Hospital80 enrolled3 locationsNCT07026994
Recruiting
Phase 2
Treatment Of Stroke reCurrence in Cerebral Amyloid Angiopathy with TraneXamic Acid (TOSCCAA- TXA)
Cerebral Amyloid Angiopathy
Alfred Health60 enrolled2 locationsACTRN12624001477516